TORCH Infections
• T=Toxoplasmosis
• O=Other ( Syphilis, HIV,Hep B ……)
• R=Rubella
• C=Cytomegalovirus (CMV)
• H=Herpes simplex (HSV)
Case scenario
• You are taking care of a term newborn male with
birth weight/length <10th
%ile. Physical exam is
normal except for a slightly enlarged liver span.
A CBC is significant for low platelets.
• What, if anything, do you worry about?
Index of Suspicion
• When do you think of TORCH infections?
▫ IUGR infants
▫ HSM
▫ Thrombocytopenia
▫ Unusual rash
▫ Concerning maternal history
▫ “Classic” findings of any specific infection
Diagnosing TORCH Infection
• Good maternal/prenatal history
▫ Remember most infections of concern are mild
illnesses often unrecognized
• Thorough exam of infant
• Directed labs/studies based on most likely
diagnosis.
TOXOPLASMOSIS
Toxoplasmosis
• Caused by protozoan – Toxoplasma gondii.
• Much higher prevalence of infection in European
countries (ie France, Greece).
• Incidence 1- 10 per 10000 live births.
Toxoplasmosis
• Domestic cat is the definitive host with
infections via:
▫ Ingestion of cysts (meats, garden products)
▫ Contact with oocysts in feces
• Acute infection in adults usually asymptomatic
(90%)
• 1/3 risk of fetal infection with primary maternal
infection in pregnancy
▫ Infection rate higher with infxn in 3rd
trimester
▫ Fetal death higher with infxn in 1st
trimester
Pnemonic – R C T
• RUBELLA - 1 ST TRIMESTER
• CYTOMEGALOVIRUS - 2 ND TRIMESTER
• TOXOPLASMOSIS - 3 RD TRIMESTER
Clinical Manifestations
• Most (70-90%) are asymptomatic at birth
• Classic triad of symptoms: {HCC}
▫ Hydrocephalus
▫ Chorioretinitis
▫ Intracranial calcifications
• Other symptoms include fever, rash, HSM,
microcephaly, seizures, jaundice, thrombocytopenia,
lymphadenopathy
• Initially asymptomatic infants are still at high risk of
developing abnormalities, especially chorioretinitis
Hydrocephalus, Calcification & Chorioretinitis
THE TRIAD
AND LATER LEADS TO………..
Diagnosis – A REAL CHALLENGE
• Maternal IgG testing indicates past infection.
• Congenital toxo. Diagnosis in newborn based on
CLINICAL SUSPICION + SEROLOGY
• Most cases ( 70 -90%) ASYMPTOMATIC.
Missed if SCREENING TESTS not done.
• Can be isolated in culture from placenta,
umbilical cord, infant serum – NOT READILY
AVAILABLE.
• PCR testing on blood,CSF, placenta
▫ Not standardized
• Newborn serologies with IgM/IgA
Toxo Screening
• Neonatal screening with IgM testing
implemented in some areas
▫ Identifies infected asymptomatic infants who may
benefit from therapy
Prevention and Treatment
• Treatment for pregnant mothers diagnosed with acute toxo
▫ Spiramycin daily
 Macrolide antibiotic
▫ Small studies have shown this reduces likelihood of congenital
transmission (up to 50%)
• If infant diagnosed prenatally, treat mother
▫ Spiramycin, pyrimethamine (anti-malarial, dihydrofolate reductase
inhib), and sulfadiazine (sulfa antibiotic)
▫ Leucovorin rescue with pyrimethamine
• Symptomatic infants
▫ Pyrimethamine (with leucovorin rescue) and sulfadiazine
▫ Treatment for 12 months total
• Asymptomatic infants
▫ Course of same medications
▫ Improved neurologic and developmental outcomes demonstrated
(compared to untreated pts or those treated for only one month)
RUBELLA
•
RUBELLA
• Single-stranded RNA virus
• Vaccine-preventable disease
• Mild, self-limiting illness
• Infection earlier in pregnancy has a higher
probability of affected infant
• { R C T remember??????)
Copyright ©2006 American Academy of PediatricsMeissner, H. C. et al. Pediatrics 2006;117:933-935
Reported rubella and CRS: United States, 1966-2004
Clinical Manifestations
• Sensorineural hearing loss (50-75%) GREG
• Cataracts and Retinopathy(20-50%) SYN.
• Cardiac malformations (20-50%)
• Neurologic (10-20%) – MR,Language
delay,microcephaly.
• Others include growth retardation, bone disease,
HSM, thrombocytopenia.
Diagnosis
• Maternal IgG may represent immunization or
past infection.
• Can isolate virus from nasal secretions
▫ Less frequently from throat, blood, urine, CSF
• Serologic testing
▫ IgM = recent postnatal or congenital infection
▫ Rising monthly IgG titers suggest congenital infection
• Diagnosis after 1 year of age difficult to establish.
Treatment
• Prevention…immunize, immunize, immunize!
• Supportive care only with parent education.
• No specific treatment.
CYTOMEGALOVIRUS
(CMV)
BLUEBERRY
MUFFIN
CYTOMEGALOVIRUS (CMV)
• Most common congenital viral infection
▫ ~40,000 infants per year in the U.S.
• Mild, self limiting illness
• Transmission can occur with primary infection
or reactivation of virus
▫ 40% risk of transmission in primary infection
• Studies suggest increased risk of transmission in
2 nd trimester of pregnancy { Remember R C T}
▫ However, more severe sequelae associated with earlier
acquisition
Clinical Manifestations
• 90% are asymptomatic at birth!
▫ Up to 15% develop symptoms later, notably
sensorineural hearing loss
{MC CAUSE OF SN. HEARING LOSS IN
CHILDREN}
• Symptomatic infection
▫ SGA, HSM, petechiae, jaundice, chorioretinitis,
periventricular calcifications, neurological
deficits
▫ >80% develop long term complications
 Hearing loss, vision impairment, developmental
delay
“Blueberry muffin” spots representing
extramedullary hematopoesis
“Blueberry muffin” spots representing
extramedullary hematopoesis
Ventriculomegaly
and calcifications of
congenital CMV
Diagnosis
• Maternal IgG shows only past infection
▫ Infection common – this is useless
• Viral isolation from urine or saliva in 1st
3weeks
of life – CULTURE – GOLD STANDARD.
▫ Afterwards may represent post-natal infection
• Viral load and DNA copies can be assessed by
PCR > 3 WKS
▫ Less useful for diagnosis, but helps in following viral
activity in patient
• Serologies not helpful given high antibody in
population !!!!!!!!!
Treatment
• Ganciclovir x6wks in symptomatic infants
▫ Studies show improvement or no progression of
hearing loss at 6mos
▫ No other outcomes evaluated (development, etc.)
▫ Neutropenia often leads to cessation of therapy
• Treatment currently not recommended in
asymptomatic infants due to side effects
HERPES SIMPLEX
Herpes Simplex (HSV)
• HSV1 or HSV2
• Primarily transmitted through infected maternal
genital tract
▫ Rationale for C-section delivery prior to
membrane rupture
• Primary infection with greater transmission risk
than reactivation
Clinical Manifestations
• Most are asymptomatic at birth
• 3 patterns of ~ equal frequency with symptoms
between birth and 4wks:
▫ Skin, eyes, mouth (SEM)
▫ CNS disease
▫ Disseminated disease (present earliest)
• Initial manifestations very nonspecific with skin
lesions NOT necessarily present
Presentations of congenital HSV
Diagnosis
• Culture of maternal lesions if present at delivery
• Cultures in infant:
▫ Skin lesions, oro/nasopharynx, eyes, urine, blood,
rectum/stool, CSF
• CSF PCR
• Serologies again not helpful given high
prevalence of HSV antibodies in population
Treatment
• High dose acyclovir 60mg/kg/day divided q8hrs
▫ X 21days for disseminated, CNS disease
▫ X 14days for SEM
SYPHILIS
SYPHILIS
• Treponema pallidum (spirochete)
• Transmitted via sexual contact
• Placental transmission as early as 6wks gestation
▫ Typically occurs during second half
▫ Mother with primary or secondary syphilis more likely
to transmit than latent disease
• Large decrease in congenital syphilis since late
1990s
▫ In 2002, only 11.2 cases/100,000 live births reported
From MMWR –From MMWR –
Aug 2004Aug 2004
Congenital Syphilis
• 2/3 of affected live-born infants are
asymptomatic at birth
• Clinical symptoms split into early or late (2 years
is cutoff)
• 3 major classifications:
▫ Fetal effects
▫ Early effects
▫ Late effects
Clinical Manifestations
• Fetal:
▫ Stillbirth
▫ Neonatal death
▫ Hydrops fetalis
• Intrauterine death in 25%
• Perinatal mortality in 25-30% if untreated
Clinical Manifestations
• Early congenital (typically 1st
5 weeks):
▫ Cutaneous lesions (palms/soles)
▫ HSM
▫ Jaundice
▫ Anemia
▫ Snuffles
▫ Periostitis
▫ Rhegades
Snuffles and Rhegades
Periostitis of long bones seen
in neonatal syphilis
Clinical Manifestations
• Late congenital:
▫ Frontal bossing
▫ Short maxilla
▫ High palatal arch
▫ Hutchinson teeth
▫ 8th
nerve deafness
▫ Saddle nose
▫ Perioral fissures
• Can be prevented with appropriate treatment
Hutchinson teeth – late result of
congenital syphilis
Diagnosing Syphilis
(Not in Newborns)
• Available serologic testing
▫ RPR/VDRL: nontreponemal test
 Sensitive but NOT specific
 Quantitative, so can follow to determine disease activity and
treatment response
▫ MHA-TP/FTA-ABS: specific treponemal test
 Used for confirmatory testing
 Qualitative, once positive always positive
• RPR/VDRL screen in ALL pregnant women
early in pregnancy and at time of birth
▫ This is easily treated!!
CDC Definition of Congenital Syphilis
• Confirmed if T. pallidum identified in skin
lesions, placenta, umbilical cord, or at
autopsy
• Presumptive diagnosis if any of:
▫ Physical exam findings
▫ CSF findings (positive VDRL)
▫ Osteitis on long bone x-rays
▫ RPR/VDRL >4 times maternal test
▫ Positive IgM antibody
Treatment
• Penicillin G is THE drug of choice for ALL
syphilis infections
• Maternal treatment during pregnancy very
effective (overall 98% success)
• Treat newborn if:
▫ They meet CDC diagnostic criteria
▫ Mother was treated <4wks before delivery
▫ Mother treated with non-PCN med
▫ Maternal titers do not show adequate response (less
than 4-fold decline)
Which TORCH Infection Presents
With…
• Snuffles?
▫ syphilis
• Hydrocephalus,Chorioretinitis,and
intracranial calcifications {HCC} ?
▫ toxo
• Blueberry muffin lesions?
▫ CMV
• Periventricular calcifications?
▫ CMV
• No symptoms?
▫ All of them !!!!!!
Which TORCH Infections Can
Absolutely Be Prevented?
• Rubella
• Syphilis
THANK YOU

Torch infections

  • 2.
    TORCH Infections • T=Toxoplasmosis •O=Other ( Syphilis, HIV,Hep B ……) • R=Rubella • C=Cytomegalovirus (CMV) • H=Herpes simplex (HSV)
  • 3.
    Case scenario • Youare taking care of a term newborn male with birth weight/length <10th %ile. Physical exam is normal except for a slightly enlarged liver span. A CBC is significant for low platelets. • What, if anything, do you worry about?
  • 4.
    Index of Suspicion •When do you think of TORCH infections? ▫ IUGR infants ▫ HSM ▫ Thrombocytopenia ▫ Unusual rash ▫ Concerning maternal history ▫ “Classic” findings of any specific infection
  • 5.
    Diagnosing TORCH Infection •Good maternal/prenatal history ▫ Remember most infections of concern are mild illnesses often unrecognized • Thorough exam of infant • Directed labs/studies based on most likely diagnosis.
  • 6.
  • 7.
    Toxoplasmosis • Caused byprotozoan – Toxoplasma gondii. • Much higher prevalence of infection in European countries (ie France, Greece). • Incidence 1- 10 per 10000 live births.
  • 9.
    Toxoplasmosis • Domestic catis the definitive host with infections via: ▫ Ingestion of cysts (meats, garden products) ▫ Contact with oocysts in feces • Acute infection in adults usually asymptomatic (90%) • 1/3 risk of fetal infection with primary maternal infection in pregnancy ▫ Infection rate higher with infxn in 3rd trimester ▫ Fetal death higher with infxn in 1st trimester
  • 10.
    Pnemonic – RC T • RUBELLA - 1 ST TRIMESTER • CYTOMEGALOVIRUS - 2 ND TRIMESTER • TOXOPLASMOSIS - 3 RD TRIMESTER
  • 11.
    Clinical Manifestations • Most(70-90%) are asymptomatic at birth • Classic triad of symptoms: {HCC} ▫ Hydrocephalus ▫ Chorioretinitis ▫ Intracranial calcifications • Other symptoms include fever, rash, HSM, microcephaly, seizures, jaundice, thrombocytopenia, lymphadenopathy • Initially asymptomatic infants are still at high risk of developing abnormalities, especially chorioretinitis
  • 12.
    Hydrocephalus, Calcification &Chorioretinitis THE TRIAD
  • 13.
    AND LATER LEADSTO………..
  • 14.
    Diagnosis – AREAL CHALLENGE • Maternal IgG testing indicates past infection. • Congenital toxo. Diagnosis in newborn based on CLINICAL SUSPICION + SEROLOGY • Most cases ( 70 -90%) ASYMPTOMATIC. Missed if SCREENING TESTS not done. • Can be isolated in culture from placenta, umbilical cord, infant serum – NOT READILY AVAILABLE. • PCR testing on blood,CSF, placenta ▫ Not standardized • Newborn serologies with IgM/IgA
  • 15.
    Toxo Screening • Neonatalscreening with IgM testing implemented in some areas ▫ Identifies infected asymptomatic infants who may benefit from therapy
  • 16.
    Prevention and Treatment •Treatment for pregnant mothers diagnosed with acute toxo ▫ Spiramycin daily  Macrolide antibiotic ▫ Small studies have shown this reduces likelihood of congenital transmission (up to 50%) • If infant diagnosed prenatally, treat mother ▫ Spiramycin, pyrimethamine (anti-malarial, dihydrofolate reductase inhib), and sulfadiazine (sulfa antibiotic) ▫ Leucovorin rescue with pyrimethamine • Symptomatic infants ▫ Pyrimethamine (with leucovorin rescue) and sulfadiazine ▫ Treatment for 12 months total • Asymptomatic infants ▫ Course of same medications ▫ Improved neurologic and developmental outcomes demonstrated (compared to untreated pts or those treated for only one month)
  • 17.
  • 18.
    RUBELLA • Single-stranded RNAvirus • Vaccine-preventable disease • Mild, self-limiting illness • Infection earlier in pregnancy has a higher probability of affected infant • { R C T remember??????)
  • 19.
    Copyright ©2006 AmericanAcademy of PediatricsMeissner, H. C. et al. Pediatrics 2006;117:933-935 Reported rubella and CRS: United States, 1966-2004
  • 21.
    Clinical Manifestations • Sensorineuralhearing loss (50-75%) GREG • Cataracts and Retinopathy(20-50%) SYN. • Cardiac malformations (20-50%) • Neurologic (10-20%) – MR,Language delay,microcephaly. • Others include growth retardation, bone disease, HSM, thrombocytopenia.
  • 22.
    Diagnosis • Maternal IgGmay represent immunization or past infection. • Can isolate virus from nasal secretions ▫ Less frequently from throat, blood, urine, CSF • Serologic testing ▫ IgM = recent postnatal or congenital infection ▫ Rising monthly IgG titers suggest congenital infection • Diagnosis after 1 year of age difficult to establish.
  • 23.
    Treatment • Prevention…immunize, immunize,immunize! • Supportive care only with parent education. • No specific treatment.
  • 24.
  • 25.
    CYTOMEGALOVIRUS (CMV) • Mostcommon congenital viral infection ▫ ~40,000 infants per year in the U.S. • Mild, self limiting illness • Transmission can occur with primary infection or reactivation of virus ▫ 40% risk of transmission in primary infection • Studies suggest increased risk of transmission in 2 nd trimester of pregnancy { Remember R C T} ▫ However, more severe sequelae associated with earlier acquisition
  • 26.
    Clinical Manifestations • 90%are asymptomatic at birth! ▫ Up to 15% develop symptoms later, notably sensorineural hearing loss {MC CAUSE OF SN. HEARING LOSS IN CHILDREN} • Symptomatic infection ▫ SGA, HSM, petechiae, jaundice, chorioretinitis, periventricular calcifications, neurological deficits ▫ >80% develop long term complications  Hearing loss, vision impairment, developmental delay
  • 27.
    “Blueberry muffin” spotsrepresenting extramedullary hematopoesis
  • 28.
    “Blueberry muffin” spotsrepresenting extramedullary hematopoesis
  • 29.
  • 30.
    Diagnosis • Maternal IgGshows only past infection ▫ Infection common – this is useless • Viral isolation from urine or saliva in 1st 3weeks of life – CULTURE – GOLD STANDARD. ▫ Afterwards may represent post-natal infection • Viral load and DNA copies can be assessed by PCR > 3 WKS ▫ Less useful for diagnosis, but helps in following viral activity in patient • Serologies not helpful given high antibody in population !!!!!!!!!
  • 31.
    Treatment • Ganciclovir x6wksin symptomatic infants ▫ Studies show improvement or no progression of hearing loss at 6mos ▫ No other outcomes evaluated (development, etc.) ▫ Neutropenia often leads to cessation of therapy • Treatment currently not recommended in asymptomatic infants due to side effects
  • 32.
  • 33.
    Herpes Simplex (HSV) •HSV1 or HSV2 • Primarily transmitted through infected maternal genital tract ▫ Rationale for C-section delivery prior to membrane rupture • Primary infection with greater transmission risk than reactivation
  • 34.
    Clinical Manifestations • Mostare asymptomatic at birth • 3 patterns of ~ equal frequency with symptoms between birth and 4wks: ▫ Skin, eyes, mouth (SEM) ▫ CNS disease ▫ Disseminated disease (present earliest) • Initial manifestations very nonspecific with skin lesions NOT necessarily present
  • 35.
  • 36.
    Diagnosis • Culture ofmaternal lesions if present at delivery • Cultures in infant: ▫ Skin lesions, oro/nasopharynx, eyes, urine, blood, rectum/stool, CSF • CSF PCR • Serologies again not helpful given high prevalence of HSV antibodies in population
  • 37.
    Treatment • High doseacyclovir 60mg/kg/day divided q8hrs ▫ X 21days for disseminated, CNS disease ▫ X 14days for SEM
  • 38.
  • 39.
    SYPHILIS • Treponema pallidum(spirochete) • Transmitted via sexual contact • Placental transmission as early as 6wks gestation ▫ Typically occurs during second half ▫ Mother with primary or secondary syphilis more likely to transmit than latent disease • Large decrease in congenital syphilis since late 1990s ▫ In 2002, only 11.2 cases/100,000 live births reported
  • 40.
    From MMWR –FromMMWR – Aug 2004Aug 2004
  • 41.
    Congenital Syphilis • 2/3of affected live-born infants are asymptomatic at birth • Clinical symptoms split into early or late (2 years is cutoff) • 3 major classifications: ▫ Fetal effects ▫ Early effects ▫ Late effects
  • 42.
    Clinical Manifestations • Fetal: ▫Stillbirth ▫ Neonatal death ▫ Hydrops fetalis • Intrauterine death in 25% • Perinatal mortality in 25-30% if untreated
  • 43.
    Clinical Manifestations • Earlycongenital (typically 1st 5 weeks): ▫ Cutaneous lesions (palms/soles) ▫ HSM ▫ Jaundice ▫ Anemia ▫ Snuffles ▫ Periostitis ▫ Rhegades
  • 44.
  • 45.
    Periostitis of longbones seen in neonatal syphilis
  • 46.
    Clinical Manifestations • Latecongenital: ▫ Frontal bossing ▫ Short maxilla ▫ High palatal arch ▫ Hutchinson teeth ▫ 8th nerve deafness ▫ Saddle nose ▫ Perioral fissures • Can be prevented with appropriate treatment
  • 47.
    Hutchinson teeth –late result of congenital syphilis
  • 48.
    Diagnosing Syphilis (Not inNewborns) • Available serologic testing ▫ RPR/VDRL: nontreponemal test  Sensitive but NOT specific  Quantitative, so can follow to determine disease activity and treatment response ▫ MHA-TP/FTA-ABS: specific treponemal test  Used for confirmatory testing  Qualitative, once positive always positive • RPR/VDRL screen in ALL pregnant women early in pregnancy and at time of birth ▫ This is easily treated!!
  • 49.
    CDC Definition ofCongenital Syphilis • Confirmed if T. pallidum identified in skin lesions, placenta, umbilical cord, or at autopsy • Presumptive diagnosis if any of: ▫ Physical exam findings ▫ CSF findings (positive VDRL) ▫ Osteitis on long bone x-rays ▫ RPR/VDRL >4 times maternal test ▫ Positive IgM antibody
  • 50.
    Treatment • Penicillin Gis THE drug of choice for ALL syphilis infections • Maternal treatment during pregnancy very effective (overall 98% success) • Treat newborn if: ▫ They meet CDC diagnostic criteria ▫ Mother was treated <4wks before delivery ▫ Mother treated with non-PCN med ▫ Maternal titers do not show adequate response (less than 4-fold decline)
  • 51.
    Which TORCH InfectionPresents With… • Snuffles? ▫ syphilis • Hydrocephalus,Chorioretinitis,and intracranial calcifications {HCC} ? ▫ toxo • Blueberry muffin lesions? ▫ CMV • Periventricular calcifications? ▫ CMV • No symptoms? ▫ All of them !!!!!!
  • 52.
    Which TORCH InfectionsCan Absolutely Be Prevented? • Rubella • Syphilis
  • 53.